Non-alcoholic Steatohepatitis: Global Impact and Clinical Consequences

نویسندگان

چکیده

Non-alcoholic steatohepatitis (NASH) is the potentially progressive form of non-alcoholic fatty liver disease (NAFLD). NAFLD and NASH are very common in most regions world on trajectory to become at a global scale. Risk for high prevalence progressiveness include visceral obesity Type 2 diabetes. The conundrum related rapid increase its burden with low awareness among general providers, as well lack widespread availability fully validated non-invasive diagnostic prognostic tests limited treatment options. Currently, lifestyle modification diet exercise best A large number clinical trials being developed provide drug therapeutic options patients moderate advanced fibrosis.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Non-Alcoholic Steatohepatitis: Pathogenesis and Clinical Management

1Division of Gastroenterology, Ospedale di Acireale, Azienda Sanitaria Provinciale di Catania, Catania, Italy 2Liver Unit, Department of Gastroenterology, Tel-Aviv Medical Center, Tel-Aviv, Israel 3School of Public Health, University of Haifa, Haifa, Israel 4Department of Biomedical Sciences and Biotechnologies, University of Catania, Catania, Italy 5Center for Human Nutrition and Atkins Center...

متن کامل

Non-Alcoholic Steatohepatitis: Clinical and Translational Research.

UNLABELLED The present review includes translational and clinical research that characterize non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). Clinical and experimental evidence led to the recognition of the key toxic role played by lipotoxicity in the pathogenesis of NAFLD. The current understanding of lipotoxicity suggests that organ injury is initiated by th...

متن کامل

Non-alcoholic steatohepatitis: the therapeutic challenge of a global epidemic

PURPOSE OF REVIEW Nonalcoholic fatty liver (NAFL) and especially its inflammatory variant nonalcoholic steatohepatitis (NASH) have become a major challenge to healthcare systems worldwide because of the increasing prevalence of its major risk factors obesity and type 2 diabetes, which are closely linked to overeating, physical inactivity, and the metabolic syndrome. RECENT FINDINGS Between 10...

متن کامل

Clinical update on non-alcoholic fatty liver disease and steatohepatitis.

Fatty liver or hepatic steatosis is a common and often occasional finding for the general practitioner. 1 After exclusion of less common causes of fatty liver such as Hepatitis B or C infection, drugs and autoimmune disorders, fatty liver is classified as non-alcoholic (NAFLD) or alcoholic fatty liver disease (AFLD) on the basis of daily eth-anol intake. The agreed threshold of ethanol intake u...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: European medical journal

سال: 2022

ISSN: ['2054-3174']

DOI: https://doi.org/10.33590/emjhepatol/22-00150